124 related articles for article (PubMed ID: 25704591)
1. Psoriasis Area and Severity Index 75 rate of classical inpatient dithranol therapy under daily life conditions.
Painsi C; Patscheider M; Inzinger M; Huegel R; Lange-Asschenfeldt B; Quehenberger F; Wolf P
Br J Dermatol; 2015 Sep; 173(3):815-7. PubMed ID: 25704591
[No Abstract] [Full Text] [Related]
2. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
[TBL] [Abstract][Full Text] [Related]
3. Eosinophilia during psoriasis treatment with TNF antagonists.
Malisiewicz B; Murer C; Pachlopnik Schmid J; French LE; Schmid-Grendelmeier P; Navarini AA
Dermatology; 2011; 223(4):311-5. PubMed ID: 22301393
[No Abstract] [Full Text] [Related]
4. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
5. Targeted 307 nm UVB-excimer light vs. topical dithranol in psoriasis.
Wollina U; Koch A; Scheibe A; Seme B; Streit I; Schmidt WD
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):122-3. PubMed ID: 21251088
[No Abstract] [Full Text] [Related]
6. Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.
Painsi C; Patscheider M; Inzinger M; Lange-Asschenfeldt B; Quehenberger F; Wolf P
J Dtsch Dermatol Ges; 2015 Nov; 13(11):1156-63. PubMed ID: 26513076
[TBL] [Abstract][Full Text] [Related]
7. Dithranol therapy in childhood psoriasis: unjustifiably on the verge of falling into oblivion.
de Jager ME; van de Kerkhof PC; de Jong EM; Seyger MM
Dermatology; 2010; 220(4):329-32. PubMed ID: 20389024
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis.
Saraswat A; Agarwal R; Katare OP; Kaur I; Kumar B
J Dermatolog Treat; 2007; 18(1):40-5. PubMed ID: 17365266
[TBL] [Abstract][Full Text] [Related]
9. Dithranol in an emulsifying oil base (bio-wash-oil) for the treatment of psoriasis of the scalp.
Wulff-Woesten A; Ohlendorf D; Henz BM; Haas N
Skin Pharmacol Physiol; 2004; 17(2):91-7. PubMed ID: 14976386
[TBL] [Abstract][Full Text] [Related]
10. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
[TBL] [Abstract][Full Text] [Related]
11. [Tazarotene increases the antipsoriatic effect of dithranol in chronic psoriasis].
Sander P; Happe M; Stücker M; Hermes N; Hoffmann K; Altmeyer P
Hautarzt; 1999 Oct; 50(10):723-7. PubMed ID: 10550358
[TBL] [Abstract][Full Text] [Related]
12. Effect of psoriasis treatment on plasma concentrations of metalloproteinase-1 and tissue inhibitor of metalloproteinases-1.
Flisiak I; Myśliwiec H; Chodynicka B
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):418-21. PubMed ID: 15987285
[TBL] [Abstract][Full Text] [Related]
13. Dithranol treatment of plaque-type psoriasis increases serum TNF-like weak inducer of apoptosis (TWEAK).
Myśliwiec H; Myśliwiec P; Baran A; Flisiak I
Adv Med Sci; 2016 Sep; 61(2):207-211. PubMed ID: 26895458
[TBL] [Abstract][Full Text] [Related]
14. [Experience in treating psoriasis patients with the preparation Ditrastic].
Mashkilleĭson AL; Golousenko IIu
Vestn Dermatol Venerol; 1989; (12):51-2. PubMed ID: 2633555
[TBL] [Abstract][Full Text] [Related]
15. [Dithranol].
Melhorn S
Hautarzt; 2017 May; 68(5):421-423. PubMed ID: 28401270
[No Abstract] [Full Text] [Related]
16. Low concentration dithranol and coal tar (Psorin) in psoriasis: a comparison with alcoholic coal tar extract and allantoin (Alphosyl).
Harrington CI
Br J Clin Pract; 1989 Jan; 43(1):27-9. PubMed ID: 2590619
[TBL] [Abstract][Full Text] [Related]
17. [Experiences in half-side treatment with tar additive to cignolin-salicylic-acid-white-vaseline therapy of psoriasis vulgaris].
Schulze HJ; Steigleder GK
Z Hautkr; 1984 May; 59(10):654-6. PubMed ID: 6741204
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and side effects of UVB-phototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis.
Sminkels OQ; Prins M; Veeniiuis RT; De Boo T; Gerritsen MJ; Van Der Wilt GJ; Van De Kerkhof PC; Van Der Valk PG
Eur J Dermatol; 2004; 14(3):159-65. PubMed ID: 15246941
[TBL] [Abstract][Full Text] [Related]
19. Hospital treatment of psoriasis. A modified anthralin program.
Farber EM; Harris DR
Arch Dermatol; 1970 Apr; 101(4):381-9. PubMed ID: 4191714
[No Abstract] [Full Text] [Related]
20. [Psoradrate (dithranol) cream].
Nyfors A
Ugeskr Laeger; 1983 Mar; 145(13):1006-7. PubMed ID: 6857800
[No Abstract] [Full Text] [Related]
[Next] [New Search]
